JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A2942 Masitinib (AB1010)

3 Citation

Target: PDGFR|c-Kit|Lyn

Summary: Tyrosine kinase inhibitor, potent and selective

≥24.95 mg/mL
A2036 Doripenem Hydrate

Target: Antibiotic

Summary: Injectable antibiotic,ultra-broad spectrum

insoluble in EtOH; ≥10.96 mg/mL
A1389 WZ4002

Summary: Mutant-selective EGFR inhibitor(L858R,T790M), irreversible and potent

≥24.7 mg/mL
A1980 SNS-032 (BMS-387032)

3 Citation

Target: Cyclin-Dependent Kinases

Summary: CDK inhibitor

insoluble in H2O; ≥19.05 mg/mL
A1882 Cediranib (AZD217)

Target: VEGFR

Summary: VEGFR inhibitor receptor,highly potent

≥22.52 mg/mL
A1736 PA-824

2 Citation

Summary: Anti-tuberculosis drug

insoluble in EtOH; insoluble in H2O; ≥17.85 mg/mL
A1630 Epothilone B (EPO906, Patupilone)

Target: Microtubules/Tubulins

Summary: Microtubule stabilizing macrolide

≥25.4 mg/mL
A2487 Odanacatib (MK-0822)

Target: Cathepsins

Summary: Cathepsin K,potent and selective

insoluble in EtOH; insoluble in H2O; ≥17.7 mg/mL
A5932 Candesartan

Summary: Angiotensin II receptor 1 (AT1) antagonist

insoluble in H2O; ≥14.65 mg/mL
A5375 Tranilast

Summary: Angiogenesis inhibitor

≥32.7 mg/mL